Prediabetes

John Anderson, MD, gives us a brief introduction to himself and talks about how, as an internal medicine specialist, he deals with a whole range of issues related to diabetes which he see in his patients. More videos with John Anderson, MD: Thoughts on SGLT-2 Inhibitors What is the ADA …

John Anderson, MD, talks about the efforts of the American Diabetes Association, and how they are using the successful experiences they have gained through landmark studies such as the Diabetes Prevention Program (DPP), applying this knowledge to new initiatives such as outreach into the community through the YMCA and other …

John Anderson, MD, talks about how clinicians should look at more than just a specific A1c number when beginning treatment for diabetes explaining that the measure is really only a way to project future risk. Factors such as family history, ethnic background and other characteristics may be more relevant. But …

John Anderson, MD, talks about the new SGLT-2 inhibitors, what he has heard so far on their efficacy, and some of the concerns that have been raised about this new class of drugs…. See more SGLT-2 Resources More videos with John Anderson, MD: John Anderson, MD, ADA Board of Directors, …

Persistent organic pollutants (POPs) are found to be prevalent in individuals with cardiometabolic complications…. 

  In this week’s Homerun Slides, we continue our exploration of the current obesity crisis with a discussion of prediabetes, the conditions which can lead to prediabetes including genetic disposition, and the possibility of preventing the onset of diabetes by acting quickly…. 

Lower test performance of HbA1c in children raises concern…. 

Sean Duffy, Co-founder & CEO, Omada Health, tells us a little about himself, how he came to be involved in starting up PreventNow.com, where the company is headed, and how they fill a niche in the market by finding ways to use their technological know-how to help solve healthcare problems. …

Sean Duffy, Omada Health, talks about why PreventNow is focused on prediabetes rather than diabetes. He explains that it was interesting to his team because of a broad clinical consensus that there is a fantastic opportunity to intervene and make a huge difference in someone’s life. A national framework already exists …

Sean Duffy, Omada Health, explains how Omada is finding its target audience, the large numbers of people in the U.S. with prediabetes who don’t even know they have it. He points out that, although many don’t know, through more biometric screenings and awareness raising programs, people are becoming aware of …